What is Dipna Pharmachem share price return in the past 10 years?

Data is not available for this company

What is the P/E ratio of Dipna Pharmachem?

The latest standalone P/E ratio of Dipna Pharmachem as of 20-Dec-2024 is 16.53.

What is the P/B ratio of Dipna Pharmachem?

The latest standalone P/B ratio of Dipna Pharmachem as of 20-Dec-2024 is 0.48.

What is the 52-week high and low of Dipna Pharmachem?

The 52-week high of Dipna Pharmachem is Rs. 14.53 and the 52-week low is Rs. 6.40.

Dipna Pharmachem Ltd - Stock Valuation and Financial Performance

Name: Dipna Pharmachem
Brand: Dipna Pharmachem

BSE: 543594 | NSE: | Trading | Small Cap

Place order

Dipna Pharma. Share Price

₹7.46 0.29 4.04%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Dipna Pharma.

Based on:

Data

M-Cap below 100cr DeciZen not available

Dipna Pharmachem stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

16.53

Market Cap:

17.9 Cr.

52-wk low:

6.4

52-wk high:

14.5

Is Dipna Pharmachem Ltd an attractive stock to invest in?

1. Is Dipna Pharmachem Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dipna Pharmachem Ltd is a below average quality company.

2. Is Dipna Pharmachem Ltd undervalued or overvalued?

The key valuation ratios of Dipna Pharmachem Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Dipna Pharmachem Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Dipna Pharmachem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Dipna Pharma.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	7.2%	8%	5.4%	3.5%	18.2%	9.2%	7.2%	-
Value Creation Index ⓘ	-0.5	-0.4	-0.6	-0.8	0.3	-0.4	-0.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	16.6	20.2	30.5	31	72.8	99.9	164	164
Sales YoY Gr.	-	21.9%	51.3%	1.5%	134.7%	37.3%	64.5%	-
Adj EPS ⓘ	3.5	5	4.4	1.2	57.1	0.6	0.5	0.5
YoY Gr.	-	43.4%	-12.8%	-72.9%	4736.4%	-98.9%	-28.6%	-
BVPS (₹) ⓘ	22.3	23.9	26.8	28	85	16.7	15.6	15.6
Adj Net Profit ⓘ	0.1	0.1	0.1	0	1.2	0.9	1.1	1
Cash Flow from Ops. ⓘ	0	0	-3.1	-2.4	2.8	-21	-5.4	-
Debt/CF from Ops. ⓘ	0	0	-3.1	-5.1	3.6	-0.8	-3.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	52.1%	74.4%	64.5%
Adj EPS ⓘ	NA	-38.2%	-27.5%	-28.6%
BVPSⓘ	NA	-8.2%	-17.7%	-6.7%
Share Price	-	-	-	-24.5%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	15.6	21.6	17.2	4.3	101	7	3.5	2.9
Op. Profit Mgn % ⓘ	2.4	2.9	1.6	1.3	3.1	2.4	2.1	NAN
Net Profit Mgn % ⓘ	0.4	0.5	0.3	0.1	1.6	0.9	0.7	0.7
Debt to Equity ⓘ	11.2	12.3	17.5	21.7	5.9	0.7	0.5	-
Working Cap Days ⓘ	0	223	192	252	152	197	212	0
Cash Conv. Cycle ⓘ	0	74	83	115	47	49	15	0

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 74.37%

Debt to equity has declined versus last 3 years average to 0.52

Return on Equity has declined versus last 3 years average to 2.90%

Net Profit has been subdued in last 3 years -27.48%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Dipna Pharmachem Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.5	-
TTM Sales (₹ Cr.)	164	-
BVPS (₹.) ⓘ	15.6	-
Reserves (₹ Cr.) ⓘ	13	-
P/BV ⓘ	0.48	-
PE ⓘ	16.53	-

From the Market
52 Week Low / High (₹)	6.40 / 14.53
All Time Low / High (₹)	6.40 / 27.61
Market Cap (₹ Cr.)	17.9
Equity (₹ Cr.)	24.1
Face Value (₹)	10
Industry PE ⓘ	62.3

Management X-Ray of Dipna Pharma.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Dipna Pharma.

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Dipna Pharma.

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	16.56	20.18	30.54	31	72.76	99.93	164.34
Operating Expenses ⓘ	16.17	19.70	30.09	30.60	70.50	97.53	160.83
Manufacturing Costs	1.46	0.44	0.08	0.06	0.41	0.13	0.09
Material Costs	14.17	18.53	28.94	29.58	68.56	95.49	157.91
Employee Cost	0.26	0.35	0.38	0.41	0.62	0.45	0.45
Other Costs ⓘ	0.28	0.37	0.68	0.55	0.91	1.46	2.38
Operating Profit ⓘ	0.38	0.48	0.45	0.40	2.26	2.40	3.50
Operating Profit Margin (%)	2.3%	2.4%	1.5%	1.3%	3.1%	2.4%	2.1%
Other Income ⓘ	0.01	0.01	0.01	0.02	0.01	0.01	0
Interest ⓘ	0.33	0.43	0.39	0.35	0.69	1.01	2.07
Depreciation ⓘ	0	0.01	0.01	0.01	0.01	0.01	0.02
Exceptional Items ⓘ	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.07	0.06	0.06	0.06	1.57	1.38	1.42
Tax ⓘ	0.01	0.02	0	0.03	0.41	0.47	0.33
Profit After Tax	0.06	0.03	0.06	0.02	1.17	0.91	1.09
PAT Margin (%)	0.4%	0.2%	0.2%	0.1%	1.6%	0.9%	0.7%
Adjusted EPS (₹)	3.0	1.6	2.9	1.2	57.1	0.6	0.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	0.46	0.49	0.55	0.57	1.74	24.36	37.52
Share Capital ⓘ	0.04	0.04	0.04	0.04	0.04	11.97	24.05
Reserves ⓘ	0.42	0.45	0.51	0.54	1.70	12.39	13.47
Minority Interest	0	0	0	0	0	0	0
Debt	5.10	6.01	9.57	12.43	10.19	15.91	19.45
Long Term Debt	0	0	3.36	3.68	5.80	10.97	12.55
Short Term Debt	5.10	6.01	6.21	8.74	4.39	4.94	6.90
Trade Payables	5.50	7.53	8.31	11.78	23.03	36.28	74.54
Others Liabilities ⓘ	0.03	0.03	0.01	0.02	1.27	1.01	1.40
Total Liabilities ⓘ	11.08	14.06	18.44	24.79	36.23	77.56	132.90
Fixed Assets
Gross Block	0.01	0.07	0.07	0.07	0.08	0.09	0.11
Accumulated Depreciation	0.01	0.02	0.03	0.03	0.04	0.05	0.07
Net Fixed Assetsⓘ	0.01	0.05	0.04	0.04	0.04	0.04	0.04
CWIP ⓘ	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0
Inventories	4.35	3.34	5.55	7.20	6.30	18.94	37.38
Trade Receivables	6	8.85	11.20	14.95	26.97	28.53	30.94
Cash Equivalents	0.30	0.12	0.18	0.25	0.21	5.69	13.88
Others Assetsⓘ	0.44	1.71	1.47	2.36	2.70	24.35	50.67
Total Assets ⓘ	11.08	14.06	18.44	24.79	36.23	77.56	132.90

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-3.12	-2.43	2.81	-20.98	-5.42
PBT ⓘ	0.06	0.06	1.57	1.38	1.42
Adjustment ⓘ	0.39	0.35	0.61	0.97	2.01
Changes in Working Capital ⓘ	-3.57	-2.82	1.03	-22.86	-8.51
Tax Paid ⓘ	0	-0.02	-0.41	-0.47	-0.34
Cash Flow From Investing Activity ⓘ	0.01	0	-0.01	-0.01	-0.01
Capex	0	-0.01	-0.01	-0.01	-0.01
Net Investments	0	0	0	0	0
Others ⓘ	0.01	0.01	0	0	0
Cash Flow From Financing Activityⓘ	3.17	2.50	-2.84	26.47	13.62
Net Proceeds from Shares ⓘ	0	0	0	21.71	12.08
Net Proceeds from Borrowing ⓘ	0.51	0.32	-0.36	0	0
Interest Paid ⓘ	-0.39	-0.35	-0.61	-0.96	-2
Dividend Paid ⓘ	0	0	0	0	0
Others ⓘ	3.05	2.53	-1.88	5.72	3.54
Net Cash Flow ⓘ	0.06	0.08	-0.04	5.48	8.19

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	13.24	6.78	11.39	4.32	101.02	6.99	3.51
ROCE (%)	7.16	7.98	5.42	3.54	18.16	9.17	7.18
Asset Turnover Ratio	1.49	1.61	1.88	1.43	2.38	1.76	1.56
PAT to CFO Conversion(x)	0	0	-52	-121.5	2.4	-23.05	-4.97
Working Capital Days
Receivable Days	132	134	120	154	105	101	66
Inventory Days	96	69	53	75	34	46	63
Payable Days	142	128	100	124	93	113	128

Dipna Pharmachem Ltd Stock News

Dipna Pharmachem Ltd FAQs

What is the share price of Dipna Pharma.?

Company share prices are keep on changing according to the market conditions. The closing price of Dipna Pharma. on 20-Dec-2024 16:59 is ₹7.46.

What is the market cap of Dipna Pharma.?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Dipna Pharma. stood at ₹17.94.

What is the P/E ratio of Dipna Pharma.?

The latest P/E ratio of Dipna Pharma. as of 20-Dec-2024 16:59 is 16.53.

What is the P/B ratio of Dipna Pharma.?

The latest P/B ratio of Dipna Pharma. as of 20-Dec-2024 16:59 is 0.48.

What is the 52-week high and low of Dipna Pharma.?

The 52-week high of Dipna Pharma. is ₹14.53 and the 52-week low is ₹6.40.

What is the TTM revenue of Dipna Pharma.?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dipna Pharma. is ₹164.3 ( Cr.) .

About Dipna Pharmachem Ltd

The company was originally incorporated as “Dipan Pharmachem Private Limited” under the provisions of Companies Act, 1956 vide Certificate of Incorporation dated July 19, 2011 bearing Corporate Identification Number issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, the name of company was changed to “Dipna Pharmachem Private Limited” and a fresh certificate of incorporation was issued by Registrar of Companies, Gujarat, Dadra and Nagar Havelli on March 29, 2012. After that, the Company was converted from Private limited to Public Limited company pursuant to a special resolution passed by shareholders at the EGM held on May 13, 2022 and consequently the name of Company was changed as “Dipna Pharmachem Limited” and a fresh certificate of incorporation was issued by the Registrar of Companies, Ahmedabad dated May 25, 2022.

The company is engaged in the trading and distribution of wide range of pharmaceutical raw material which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. Presently its product portfolio comprises of 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovasculars, Anti - Bactaria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc. Being a trading and distribution company, it has pan India market for its products. The company had also started the selling of chemicals on commission basis. In the financial year 2022, the company had earned commission income of Rs 127.50 lakh. The company is doing trading in Ahmedabad and surrounding area of Ahmedabad.

Business area of the company

Dipna Pharmachem is a trader, importer, and exporter in industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation since 2011. The company’s huge portfolio includes expertise for marketing and sourcing of industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation and intermediates, assistance in setting up contract manufacturing compliance for regulated, semi-regulated pharmaceutical companies with all the global benchmark parameters of leading certificates like WHO-GMP.